If you’ve been following developments in the UK’s R&D tax landscape, you might have noticed a subtle but important shift.

If you’ve been following developments in the UK’s R&D tax landscape, you might have noticed a subtle but important shift. Recent changes to the Additional Information Form (AIF) may seem minor on their own, but combined with the government’s £55 billion commitment to frontier technologies, they point to a broader shift, one where the government may take a more hands-on approach to determining which types of innovation are encouraged, scrutinised, or quietly discouraged.
Is this a sensible step toward safeguarding the integrity of the scheme, or a move that risks overregulation and unintended barriers to innovation?
Without delving into the full list, a recent update to the AIF now flags certain Companies House SIC codes as sectors that “don’t usually conduct R&D”. In effect, HMRC has introduced a list of industries whose claims from these sectors are more likely to trigger an HMRC enquiry.
While enhancing AIF processes at Novel, we came across this list unexpectedly. In doing so, we discovered which SIC codes HMRC has quietly flagged, confirming what many in the industry have long suspected, that SIC codes are now being actively used in R&D compliance.
Many of these flagged SIC codes aren’t traditionally associated with R&D activity. I’m not going to pretend that “Residential nursing care facilities” hasn’t been identified as a ‘high-risk’ sector in the recent fraud crackdowns. In fact, HMRC’s website has already listed examples of sectors that are “rarely eligible” which includes care homes, personal training, wholesalers, and restaurants. Still, it’s one thing to assume HMRC considers SIC codes in the background when assessing claims, it’s another to see this become an explicit part of the process.
In theory, this could help reduce misuse of the scheme. Responsible accountants can use these flags to guide clients on eligibility. But that assumes everyone plays by the rules. In practice, less scrupulous advisers might ignore these warnings. And what’s to stop companies, once aware of these flags, from changing their SIC code to slip through the cracks?
On one hand, it’s hard to argue that a company involved in, say, the wholesale of live animals, is conducting genuine R&D. On the other hand, relying too heavily on SIC codes risks oversimplifying a complex picture. It would be more constructive for HMRC to assess each claim on its own merits rather than lean on automated filters that could exclude valid innovation. Do we risk drifting towards a system where innovation is defined not by what a company actually does, but by how it’s categorised on paper?
Alongside these compliance changes, the Department for Science, Innovation and Technology recently announced a £55 billion investment in frontier technologies such as quantum technologies, robotics, engineering biology, advanced materials, clean manufacturing, cancer diagnostics, and next-generation scanners. This is one of the largest real-time investments in UK R&D, a clear indication of long-term government support for innovation.
On one hand, this is reassuring for most R&D advisers and their clients, it shows that government support for R&D remains strong. However, directing funding towards specific sectors may also signal which types of innovation the Treasury considers important. This, combined with the AIF updates, could introduce a sector bias into the R&D scheme.
The above risks shifting the R&D scheme from a broadly accessible programme, open to any company from any sector demonstrating genuine scientific or technological innovation, towards one that favours certain industries. Steering innovators into specific sectors through policy or bureaucracy could create unintended consequences for companies outside those sectors.
While R&D tax relief wasn’t a headline feature of the Budget, the fact that nothing substantive changed is worth noting. The merged scheme will continue, and no new rules have been introduced.
One announcement of interest was the introduction of a new targeted R&D Advance Assurance service, scheduled for spring 2026. Designed for SMEs, it will allow businesses to confirm in advance whether their projects qualify as R&D for tax purposes. Importantly, it should provide clarity on challenging areas such as eligibility of overseas expenditure, claims for contracted-out work, and whether a company meets the exemption from the PAYE/NICs cap. In essence, it will give SMEs confidence that their future claims will be accepted before submission.
Overall, this Budget signals a clear intention to back innovation as a driver of UK growth. That said, much depends on how these measures are delivered in practice. For now, the R&D tax relief landscape remains, thankfully, steady and unchanged.
This will be my final newsletter of the year. I’d like to wish everyone a very happy holiday, and I’ll be back in January with a fresh perspective, reflecting on the highlights of 2025 and looking ahead to what 2026 may bring.